Fulgent Genetics, Inc.
FLGTNasdaq
$20.16
↓ -1.9%Jul 17 close · end-of-day
Price
1Y↑ +11.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$622.6M
Enterprise Value
$346.3M
P/E
—
P/S
1.9
P/B
0.6
EV/EBITDA
—
PEG
—
FCF Yield
-18.2%
Dividend Yield
—
Revenue (TTM)
$320.3M
Net Income (TTM)
-$73.8M
Free Cash Flow (TTM)
-$113.2M
Gross Margin
38.7%
Operating Margin
-33.1%
Net Margin
-23.0%
ROE
-7.0%
ROIC
-10.8%
Debt / Equity
—
Net Cash
$276.3M
Return 1Y
+11.2%
Company profile
Fulgent Genetics, Inc. provides COVID-19, molecular diagnostic, and genetic testing services in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests. It also provides next generation sequencing and reverse transcription polymerase chain reaction-based tests for the detection of SARS-CoV-2.
- CEO
- Ming Hsieh
- Sector
- Services
- Industry
- Healthcare
- Employees
- 1,010
- Headquarters
- California
- Website
- fulgentgenetics.com
Management & directors
- Gao HanlinChief Scientific Officer
- Xie JianPresident and COO
- Hsieh MingChief Executive Officer
- Kim PaulCFO and Treasurer
Roles derived from SEC Form 4 filings.
Earnings
FLGT Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$71.1M↓ -3.2%
Diluted EPS——
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $421.7M | $992.6M | $619.0M | $289.2M | $283.5M | $322.7M |
| Gross profit | $331.9M | $777.1M | $366.9M | $104.5M | $107.2M | $130.9M |
| Operating income | $290.2M | $676.0M | $178.5M | -$195.5M | -$73.9M | -$91.1M |
| Net income | $214.3M | $507.4M | $143.4M | -$167.8M | -$42.7M | -$60.5M |
| Diluted EPS | — | — | — | — | — | — |
| Operating cash flow | $140.6M | $538.6M | $253.5M | $27.0M | $21.1M | -$101.6M |
| Free cash flow | $105.5M | $514.8M | $234.7M | $4.8M | -$19.3M | -$124.2M |
| Gross margin | 78.7% | 78.3% | 59.3% | 36.1% | 37.8% | 40.6% |
| Operating margin | 68.8% | 68.1% | 28.8% | -67.6% | -26.1% | -28.2% |
| Net margin | 50.8% | 51.1% | 23.2% | -58.0% | -15.1% | -18.8% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $71.0M | $71.7M | $76.2M | $73.5M | $81.8M | $84.1M | $83.3M | $71.1M |
| Gross profit | $26.5M | $26.8M | $31.8M | $28.3M | $34.4M | $35.5M | $32.6M | $21.5M |
| Operating income | -$18.9M | -$17.1M | -$16.1M | -$19.8M | -$19.7M | -$15.3M | -$36.2M | -$34.6M |
| Net income | -$8.7M | -$14.6M | -$5.9M | -$11.5M | -$19.0M | -$6.6M | -$23.4M | -$24.8M |
| Diluted EPS | — | — | — | — | — | — | — | — |
| Operating cash flow | $4.3M | -$15.5M | $25.0M | -$4.4M | -$30.2M | $11.1M | -$78.1M | $7.1M |
| Free cash flow | -$8.7M | -$35.0M | $21.2M | -$9.1M | -$37.0M | $5.1M | -$83.1M | $1.9M |
| Gross margin | 37.3% | 37.3% | 41.8% | 38.6% | 42.1% | 42.2% | 39.1% | 30.2% |
| Operating margin | -26.6% | -23.8% | -21.2% | -26.9% | -24.1% | -18.3% | -43.5% | -48.7% |
| Net margin | -12.3% | -20.4% | -7.7% | -15.7% | -23.2% | -7.9% | -28.1% | -34.9% |
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-02 | Xie Jian· President and COO | Sale | 2,146 | $17.89 | $38,382.28 | filing |
| 2026-06-02 | Gao Hanlin· Chief Scientific Officer | Sale | 1,688 | $17.89 | $30,190.72 | filing |
| 2026-06-01 | Hsieh Ming· Chief Executive Officer | Tax withholding | 4,392 | $18.09 | $79,451.28 | filing |
| 2026-06-01 | KIM PAUL· CFO and Treasurer | Tax withholding | 2,087 | $18.09 | $37,753.83 | filing |
| 2026-05-27 | Xie Jian· President and COO | Sale | 1,201 | $17.60 | $21,137.60 | filing |
| 2026-05-27 | Gao Hanlin· Chief Scientific Officer | Sale | 945 | $17.60 | $16,632.00 | filing |
| 2026-05-26 | Hsieh Ming· Chief Executive Officer | Tax withholding | 2,949 | $17.67 | $52,108.83 | filing |
| 2026-05-26 | KIM PAUL· CFO and Treasurer | Tax withholding | 1,168 | $17.67 | $20,638.56 | filing |
| 2026-05-14 | Nohaile Michael | Award | 5,558 | $0.00 | $0.00 | filing |
| 2026-05-14 | GROVES REGINA E | Award | 11,117 | $0.00 | $0.00 | filing |
| 2026-05-14 | Marsh Linda | Award | 11,117 | $0.00 | $0.00 | filing |
| 2026-04-26 | Xie Jian· President and COO | Tax withholding | 4,361 | $16.31 | $71,127.91 | filing |
| 2026-04-26 | KIM PAUL· CFO and Treasurer | Tax withholding | 2,747 | $16.31 | $44,803.57 | filing |
| 2026-04-26 | Gao Hanlin· Chief Scientific Officer | Tax withholding | 1,645 | $16.31 | $26,829.95 | filing |
| 2026-03-01 | Hsieh Ming· Chief Executive Officer | Tax withholding | 17,566 | $15.33 | $269,286.78 | filing |
| 2026-03-01 | KIM PAUL· CFO and Treasurer | Tax withholding | 8,347 | $15.33 | $127,959.51 | filing |
| 2026-03-01 | Xie Jian· President and COO | Tax withholding | 8,147 | $15.33 | $124,893.51 | filing |
| 2026-03-01 | Gao Hanlin· Chief Scientific Officer | Tax withholding | 6,410 | $15.33 | $98,265.30 | filing |
| 2026-03-01 | KIM PAUL· CFO and Treasurer | Tax withholding | 1,133 | $15.33 | $17,368.89 | filing |
| 2026-03-01 | Xie Jian· President and COO | Tax withholding | 1,079 | $15.33 | $16,541.07 | filing |
| 2026-03-01 | Gao Hanlin· Chief Scientific Officer | Tax withholding | 1,018 | $15.33 | $15,605.94 | filing |
| 2026-02-26 | Hsieh Ming· Chief Executive Officer | Tax withholding | 2,949 | $24.76 | $73,017.24 | filing |
| 2026-02-26 | KIM PAUL· CFO and Treasurer | Tax withholding | 1,168 | $24.76 | $28,919.68 | filing |
| 2026-02-26 | Xie Jian· President and COO | Tax withholding | 1,140 | $24.76 | $28,226.40 | filing |
| 2026-02-26 | Gao Hanlin· Chief Scientific Officer | Tax withholding | 897 | $24.76 | $22,209.72 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.